頚椎症治療の世界市場レポート 2025年

頚椎症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年には81億9,000万米ドルに成長し、CAGRは6.7％となります。予測期間の成長は、ヘルスケア投資の拡大、低侵襲処置の採用、患者の意識と教育の向上、予防対策への注目の高まり、治療アプローチにおける遠隔医療の統合などに起因すると考えられます。予測期間における主な動向としては、個別化治療計画、非外科的介入の増加、在宅治療ソリューションの開発、デジタルヘルスプラットフォームの統合、全人的・集学的アプローチの重視などが挙げられます。

頸椎症の有病率の上昇は、今後の頚椎症治療市場の成長を促進すると予測されます。頸椎症は、頸椎（首の部分）の関節や椎間板に影響を及ぼす変性疾患です。この疾患の治療は、痛みを和らげ、個人の活動レベルを維持し、罹患者の脊髄や神経への不可逆的な損傷を防ぎ、全体的な幸福を高めることを目的としています。例えば、2023年5月、米国の政府機関である国立衛生研究所（National Institute of Health）は、頸椎症は老化現象の正常な一面と考えられており、65歳までに95％の人が罹患すると述べています。その結果、頸椎症の有病率の増加が、この市場における治療オプションの需要に拍車をかけています。

ヘルスケア支出の増加は、頚椎症治療市場の拡大に拍車をかける。ヘルスケア支出には、家族計画、栄養、緊急医療支援など、健康増進に主眼を置いたヘルスケアサービスの提供に関連する費用が含まれます。ヘルスケア支出の増加は、患者の意識を高め、早期診断を促進し、頸椎症の包括的な管理を可能にする上で重要です。例えば、メディケア＆メディケイド・サービスセンターが2022年3月に発表した2021-2030年国民医療費（NHE）報告書に概説されているように、国民医療費は2021年から2030年にかけて年平均5.1％の成長率を示し、2030年には約6兆8,000億米ドルに達する可能性があると予測されています。その結果、医療支出の増加は頚椎症治療市場を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界頚椎症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の頚椎症治療市場：成長率分析
• 世界の頚椎症治療市場の実績：規模と成長, 2019-2024
• 世界の頚椎症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界頚椎症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の頚椎症治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 理学療法
• 手術
• 世界の頚椎症治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 若者
• お年寄り
• 世界の頚椎症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• ホームケア設定
• 世界の頚椎症治療市場、医薬品の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• 非ステロイド性抗炎症薬（NSAID）
• 筋弛緩剤
• コルチコステロイド
• 神経障害性疼痛治療薬
• 世界の頚椎症治療市場、理学療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手技療法
• 運動療法
• 牽引力
• 電気療法
• 姿勢トレーニング
• 世界の頚椎症治療市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 椎間板切除術
• 頸椎固定術
• 椎弓切除術
• 孔切開術
• 人工椎間板置換術

第7章 地域別・国別分析

• 世界の頚椎症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の頚椎症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 頚椎症治療市場：競合情勢
• 頚椎症治療市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• C.H. Boehringer Sohn AG & Co. KG
• Amgen Inc.
• Stryker Corporation
• B. Braun SE
• Zimmer Biomet Holdings Inc.
• UCB Pharma S.A.
• Integra LifeSciences
• NuVasive Inc.
• Globus Medical Inc.
• Orthofix Medical Inc.
• Aesculap Implant Systems LLC
• Titan Spine Inc.
• Exactech Inc.
• SeaSpine Inc.
• RTI Surgical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 頚椎症治療市場2029：新たな機会を提供する国
• 頚椎症治療市場2029：新たな機会を提供するセグメント
• 頚椎症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cervical spondylosis treatment involves therapeutic interventions for a degenerative condition affecting the cervical spine (neck region) caused by wear and tear of spinal discs, joints, and bones. These treatments aim to alleviate pain, maintain individuals' activity levels, and prevent irreversible damage to the spinal cord and nerves.

The primary types of cervical spondylosis treatment include medications, physical therapy, and surgery. Medications are substances used for diagnosing, preventing, treating, or managing various medical conditions and diseases. In the context of cervical spondylosis treatment, medications are employed to reduce inflammation and alleviate symptoms associated with the condition. These treatments cater to both youth and the elderly and are administered in different settings, such as hospitals, ambulatory surgical centers, and homecare.

The cervical spondylosis treatment market research report is one of a series of new reports from The Business Research Company that provides cervical spondylosis treatment market statistics, including cervical spondylosis treatment industry global market size, regional shares, competitors with a cervical spondylosis treatment market share, detailed cervical spondylosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the cervical spondylosis treatment industry. This cervical spondylosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cervical spondylosis treatment market size has grown strongly in recent years. It will grow from $5.94 billion in 2024 to $6.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to aging population, increased prevalence of sedentary lifestyles, growth in awareness of cervical spondylosis, expansion of healthcare infrastructure, rise in musculoskeletal disorders

The cervical spondylosis treatment market size is expected to see strong growth in the next few years. It will grow to $8.19 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing healthcare investments, adoption of minimally invasive procedures, rise in patient awareness and education, increasing focus on preventive measures, integration of telemedicine in treatment approaches. Major trends in the forecast period include personalized treatment plans, rise of non-surgical interventions, development of home-based therapeutic solutions, integration of digital health platforms, emphasis on holistic and multidisciplinary approaches.

The rising prevalence of cervical spondylosis is anticipated to drive the growth of the cervical spondylosis treatment market in the future. Cervical spondylosis is a degenerative condition that impacts the joints and discs in the cervical spine (neck area). Treatments for this condition aim to alleviate pain, maintain individuals' activity levels, prevent irreversible damage to the spinal cord and nerves in those affected, and enhance overall well-being. For example, in May 2023, the National Institute of Health, a US-based government organization, stated that cervical spondylosis is considered a normal aspect of the aging process, affecting 95% of individuals by the age of 65. As a result, the growing prevalence of cervical spondylosis is fueling the demand for treatment options in this market.

The rise in healthcare expenditure is poised to fuel the expansion of the cervical spondylosis treatment market. Healthcare expenditure encompasses costs associated with providing health services, including aspects such as family planning, nutrition, and emergency medical assistance, with a primary focus on promoting health. Increased healthcare spending is instrumental in elevating patient awareness, facilitating early diagnosis, and enabling comprehensive management of cervical spondylosis. For instance, as outlined in the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services in March 2022, national health spending was projected to experience an average annual growth rate of 5.1% between 2021 and 2030, potentially reaching approximately $6.8 trillion by 2030. Consequently, the escalating healthcare expenditure serves as a significant driver propelling the cervical spondylosis treatment market.

Product innovations are a significant trend gaining traction in the cervical spondylosis treatment market. Leading companies in this sector are launching innovative products to maintain their market position. For example, in February 2024, NGMedical GmbH, a medical technology manufacturer based in Germany, introduced the MOVE-C artificial cervical disc in the United Arab Emirates, representing a noteworthy advancement in its global commercialization strategy. The first implantation of the MOVE-C disc took place in Abu Dhabi, showcasing the device's advanced design, which facilitates physiological movement and encourages bone ingrowth. This launch corresponds with the rising demand for innovative spinal treatments in the region, fueled by an increase in spinal disorders and population growth. Overall, the introduction of the MOVE-C is expected to improve patient outcomes and positively impact the artificial disc replacement market in the MENA region.

Prominent players in the market are strategically prioritizing the development of cutting-edge products, such as spinal support systems, to address the changing demands of patients and advancements in technology. Specifically, Aspen Medical Products, a US-based provider of solutions for pain and mobility management, unveiled the VRTX System in October 2023. This groundbreaking spine support system is meticulously crafted to offer comprehensive coverage from the cervical to sacrum regions. The VRTX System aims to revolutionize acute spinal care through its user-friendly prefabricated design and easily adjustable sizing, enabling healthcare professionals to promptly fit patients and stabilize their spines. This off-the-shelf solution is expected to reduce hospital stays, minimize complications, and enhance operational efficiency by optimizing time and inventory management. Featuring prefabricated components like CTO, TLSO, LSO, and CTLSO, each element within the VRTX System ensures optimal motion restriction and can be tailored to meet the specific needs of individual patients. This modular approach supports standardization of products and services within hospitals, promoting staff efficiency and elevating overall patient care.

In August 2023, ZimVie Inc., a US-based life sciences company operating in the dental and spine markets, announced an expansion of its collaboration agreement with Brainlab, a Germany-based leader in spine imaging, planning, and navigation solutions, incorporating robotic imaging, surgical assistance, and mixed reality technologies. This collaboration aims to merge ZimVie's Vital and Virage fixation systems with Brainlab's spine and trauma navigation technologies. By leveraging Brainlab's expertise, surgeons can effectively plan and execute spinal procedures, accurately position pedicle screws, and minimize radiation exposure, thereby enhancing the precision and safety of spinal surgeries.

Major companies operating in the cervical spondylosis treatment market include Johnson & Johnson, Merck & Co Inc., AbbVie Inc., GlaxoSmithKline Plc, Medtronic PLC, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Stryker Corporation, B. Braun SE, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Integra LifeSciences, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., Aesculap Implant Systems LLC, Titan Spine Inc., Exactech Inc., SeaSpine Inc., RTI Surgical, Xtant Medical Holdings Inc., Zavation Medical Products LLC, Wenzel Spine Inc., Life Spine Inc., Spineology Inc., VGI Medical LLC, Dynamic Spine Inc., Synthes Holding AG, ZygoFix Ltd.

North America was the dominant region in the cervical spondylosis treatment market in 2024. The regions covered in the cervical spondylosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cervical spondylosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cervical spondylosis treatment market consists of revenues earned by entities by providing physical therapy services, neck traction services, diagnosis, consultation, and surgical services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cervical spondylosis treatment market also includes the sales of nonsteroidal anti-inflammatory drugs, corticosteroids, and anti-seizure medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cervical Spondylosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cervical spondylosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cervical spondylosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cervical spondylosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type of Treatment: Medications; Physical Therapy; Surgery
• 2) By Application: Youth; Elderly
• 3) By End User: Hospitals; Ambulatory Surgical Centers; Homecare Settings
• Subsegments:
• 1) By Medications: Analgesics; Non-steroidal Anti-inflammatory Drugs (NSAIDs); Muscle Relaxants; Corticosteroids; Neuropathic Pain Medications
• 2) By Physical Therapy: Manual Therapy; Exercise Therapy; Traction; Electrotherapy; Posture Training
• 3) By Surgery: Discectomy; Cervical Fusion; Laminectomy; Foraminotomy; Artificial Disc Replacement
• Companies Mentioned: Johnson & Johnson; Merck & Co Inc.; AbbVie Inc.; GlaxoSmithKline Plc; Medtronic PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cervical Spondylosis Treatment Market Characteristics

3. Cervical Spondylosis Treatment Market Trends And Strategies

4. Cervical Spondylosis Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Cervical Spondylosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cervical Spondylosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cervical Spondylosis Treatment Market Growth Rate Analysis
• 5.4. Global Cervical Spondylosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cervical Spondylosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cervical Spondylosis Treatment Total Addressable Market (TAM)

6. Cervical Spondylosis Treatment Market Segmentation

• 6.1. Global Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Physical Therapy
• Surgery
• 6.2. Global Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Youth
• Elderly
• 6.3. Global Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings
• 6.4. Global Cervical Spondylosis Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Muscle Relaxants
• Corticosteroids
• Neuropathic Pain Medications
• 6.5. Global Cervical Spondylosis Treatment Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manual Therapy
• Exercise Therapy
• Traction
• Electrotherapy
• Posture Training
• 6.6. Global Cervical Spondylosis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Discectomy
• Cervical Fusion
• Laminectomy
• Foraminotomy
• Artificial Disc Replacement

7. Cervical Spondylosis Treatment Market Regional And Country Analysis

• 7.1. Global Cervical Spondylosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cervical Spondylosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cervical Spondylosis Treatment Market

• 8.1. Asia-Pacific Cervical Spondylosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cervical Spondylosis Treatment Market

• 9.1. China Cervical Spondylosis Treatment Market Overview
• 9.2. China Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cervical Spondylosis Treatment Market

• 10.1. India Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cervical Spondylosis Treatment Market

• 11.1. Japan Cervical Spondylosis Treatment Market Overview
• 11.2. Japan Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cervical Spondylosis Treatment Market

• 12.1. Australia Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cervical Spondylosis Treatment Market

• 13.1. Indonesia Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cervical Spondylosis Treatment Market

• 14.1. South Korea Cervical Spondylosis Treatment Market Overview
• 14.2. South Korea Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cervical Spondylosis Treatment Market

• 15.1. Western Europe Cervical Spondylosis Treatment Market Overview
• 15.2. Western Europe Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cervical Spondylosis Treatment Market

• 16.1. UK Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cervical Spondylosis Treatment Market

• 17.1. Germany Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cervical Spondylosis Treatment Market

• 18.1. France Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cervical Spondylosis Treatment Market

• 19.1. Italy Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cervical Spondylosis Treatment Market

• 20.1. Spain Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cervical Spondylosis Treatment Market

• 21.1. Eastern Europe Cervical Spondylosis Treatment Market Overview
• 21.2. Eastern Europe Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cervical Spondylosis Treatment Market

• 22.1. Russia Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cervical Spondylosis Treatment Market

• 23.1. North America Cervical Spondylosis Treatment Market Overview
• 23.2. North America Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cervical Spondylosis Treatment Market

• 24.1. USA Cervical Spondylosis Treatment Market Overview
• 24.2. USA Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cervical Spondylosis Treatment Market

• 25.1. Canada Cervical Spondylosis Treatment Market Overview
• 25.2. Canada Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cervical Spondylosis Treatment Market

• 26.1. South America Cervical Spondylosis Treatment Market Overview
• 26.2. South America Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cervical Spondylosis Treatment Market

• 27.1. Brazil Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cervical Spondylosis Treatment Market

• 28.1. Middle East Cervical Spondylosis Treatment Market Overview
• 28.2. Middle East Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cervical Spondylosis Treatment Market

• 29.1. Africa Cervical Spondylosis Treatment Market Overview
• 29.2. Africa Cervical Spondylosis Treatment Market, Segmentation By Type of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cervical Spondylosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cervical Spondylosis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cervical Spondylosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Cervical Spondylosis Treatment Market Competitive Landscape
• 30.2. Cervical Spondylosis Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

31. Cervical Spondylosis Treatment Market Other Major And Innovative Companies

• 31.1. C.H. Boehringer Sohn AG & Co. KG
• 31.2. Amgen Inc.
• 31.3. Stryker Corporation
• 31.4. B. Braun SE
• 31.5. Zimmer Biomet Holdings Inc.
• 31.6. UCB Pharma S.A.
• 31.7. Integra LifeSciences
• 31.8. NuVasive Inc.
• 31.9. Globus Medical Inc.
• 31.10. Orthofix Medical Inc.
• 31.11. Aesculap Implant Systems LLC
• 31.12. Titan Spine Inc.
• 31.13. Exactech Inc.
• 31.14. SeaSpine Inc.
• 31.15. RTI Surgical

32. Global Cervical Spondylosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cervical Spondylosis Treatment Market

34. Recent Developments In The Cervical Spondylosis Treatment Market

35. Cervical Spondylosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Cervical Spondylosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cervical Spondylosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cervical Spondylosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer